| Literature DB >> 23715538 |
Kazutoshi Takahashi1, Shinya Yamanaka.
Abstract
Differentiated cells can be reprogrammed to pluripotency and other cell fates by treatment with defined factors. The discovery of induced pluripotent stem cells (iPSCs) has opened up unprecedented opportunities in the pharmaceutical industry, in the clinic and in laboratories. In particular, the medical applications of human iPSCs in disease modeling and stem cell therapy have been progressing rapidly. The ability to induce cell fate conversion is attractive not only for these applications, but also for basic research fields, such as development, cancer, epigenetics and aging.Entities:
Keywords: Disease modeling; Reprogramming; Stem cell; Therapy; iPSCs
Mesh:
Substances:
Year: 2013 PMID: 23715538 DOI: 10.1242/dev.092551
Source DB: PubMed Journal: Development ISSN: 0950-1991 Impact factor: 6.868